Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | 5.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 0.91 | 1.73 |
NAV | ₹15.60 | ₹31.44 |
Fund Started | 14 Feb 2022 | 27 Sep 2019 |
Fund Size | ₹548.54 Cr | ₹9001.07 Cr |
Exit Load | - | Exit load of 1% if redeemed within 1 year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.64% | 26.71% |
3 Year | - | 20.93% |
5 Year | - | 23.52% |
1 Year
3 Year
5 Year
Equity | 100.03% | 98.82% |
Cash | -0.03% | 1.18% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 4.24% |
ICICI Bank Ltd. | 4.01% |
Page Industries Ltd. | 3.94% |
Dr. Reddy's Laboratories Ltd. | 3.93% |
HDFC Bank Ltd. | 3.81% |
ITC Ltd. | 3.78% |
Apollo Hospitals Enterprise Ltd. | 3.63% |
Bharti Airtel Ltd. | 3.62% |
MRF Ltd. | 3.54% |
Abbott India Ltd. | 3.48% |
Name | Assets |
---|---|
Zomato Ltd. | 6.91% |
Trent Ltd. | 6.63% |
Kalyan Jewellers India Ltd. | 4.88% |
Bharti Airtel Ltd. | 4.48% |
Coforge Ltd. | 3.77% |
Samvardhana Motherson International Ltd. | 3.46% |
Mankind Pharma Ltd. | 3.22% |
Premier Energies Ltd. | 3.18% |
Prestige Estates Projects Ltd. | 3.16% |
Amber Enterprises India Ltd. | 3.06% |
Name | Sharwan Kumar Goyal | Ajay Khandelwal |
Start Date | 02 Jul 2018 | 16 Dec 2021 |
Name
Start Date
Description | The scheme seeks to provide returns that, before expenses, closely correspond to the total returns of the securities as represented by the underlying index, subject to tracking error. | The Scheme seeks to provide medium to long-term capital appreciation by investing primarily in Large and Midcap stocks. |
Launch Date | 14 Feb 2022 | 27 Sep 2019 |
Description
Launch Date